Skip to content
Cardiovascular healthCohort study3 min read

Systolic blood pressure of 130 mmHg or more at age 50 linked to higher dementia risk

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. · European heart journal · 2018 · Original paper ↗

Key takeaway

In 8639 people from the Whitehall II cohort, systolic blood pressure of 130 mmHg or higher at age 50 was linked to a higher dementia risk (HR 1.38; 95% CI 1.11, 1.70), but no link was seen at age 60 or 70. This is an observational association with dementia recorded from health records, so it does not show that lowering blood pressure at 50 prevents dementia.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

High blood pressure is a suspected risk factor for dementia, but the age at which it matters and the threshold that counts are unclear. The authors tested whether systolic and diastolic blood pressure at age 50, 60 and 70 were linked to later dementia, and whether cardiovascular disease explained any link.

Who and how

Cohort study. Systolic and diastolic blood pressure were measured in 8639 persons (32.5% women) of the Whitehall II cohort in 1985, 1991, 1997 and 2003. Dementia (385 of 8639) was identified from electronic health records followed up until 2017. The authors used cubic splines and Cox regression adjusted for sociodemographic factors, health behaviours and time-varying chronic conditions, and multi-state models to look at the role of cardiovascular disease (CVD) during follow-up.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Systolic blood pressure of 130 mmHg or more at age 50 was linked to higher dementia risk (HR 1.38; 95% CI 1.11, 1.70), but not at age 60 or 70.
  2. 2
    Diastolic blood pressure was not associated with dementia.
  3. 3
    Longer exposure to systolic pressure of 130 mmHg or more between mean ages of 45 and 61 years was linked to higher risk than no or low exposure (HR 1.29, 95% CI 1.00, 1.66).
  4. 4
    Among people who stayed free of CVD during follow-up, systolic pressure of 130 mmHg or more at age 50 was linked to greater dementia risk (HR 1.47, 95% CI 1.15, 1.87), suggesting the excess risk is independent of CVD.

Limits & uncertainty

  1. 1
    This is an observational cohort, so blood pressure may be a marker for other differences between people even after adjustment, and the findings do not show that treating it lowers dementia risk.
  2. 2
    Dementia was identified from electronic health records, which can miss or delay recognition of cases; only 385 cases occurred.
  3. 3
    The Whitehall II cohort is made up of 32.5% women, so findings may apply less to women and to groups beyond this cohort.
  4. 4
    The CI for the longer-exposure result starts at 1.00, so that estimate is borderline.

What to take from it

The study suggests that blood pressure in midlife, even below the conventional 140 mmHg hypertension threshold, may be relevant for later brain health. It does not tell any person what their target should be, or whether to start or change treatment; that decision belongs with your clinician.

Reading your own data

A home blood pressure cuff is the right tool here. Measure at the same time of day, seated and rested, with the same validated cuff, and look at the average of repeated readings and the trend across weeks rather than one number. Share the log with your clinician.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Aims

To examine associations of diastolic and systolic blood pressure (SBP) at age 50, 60, and 70 years with incidence of dementia, and whether cardiovascular disease (CVD) over the follow-up mediates this association.

Methods and results

Systolic and diastolic blood pressure were measured on 8639 persons (32.5% women) from the Whitehall II cohort study in 1985, 1991, 1997, and 2003. Incidence of dementia (n dementia/n total = 385/8639) was ascertained from electronic health records followed-up until 2017. Cubic splines using continuous blood pressure measures suggested SBP ≥130 mmHg at age 50 but not at age 60 or 70 was associated with increased risk of dementia, confirmed in Cox regression analyses adjusted for sociodemographic factors, health behaviours, and time varying chronic conditions [hazard ratio (HR) 1.38; 95% confidence interval (95% CI) 1.11, 1.70]. Diastolic blood pressure was not associated with dementia. Participants with longer exposure to hypertension (SBP ≥ 130 mmHg) between mean ages of 45 and 61 years had an increased risk of dementia compared to those with no or low exposure to hypertension (HR 1.29, 95% CI 1.00, 1.66). In multi-state models, SBP ≥ 130 mmHg at 50 years of age was associated with greater risk of dementia in those free of CVD over the follow-up (HR 1.47, 95% CI 1.15, 1.87).

Conclusion

Systolic blood pressure ≥130 mmHg at age 50, below the conventional ≥140 mmHg threshold used to define hypertension, is associated with increased risk of dementia; in these persons this excess risk is independent of CVD.

Sources & attribution

Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension.

Abell JG, Kivimäki M, Dugravot A, Tabak AG, Fayosse A, Shipley M, Sabia S, Singh-Manoux A.

European heart journal · 2018-09-01

DOI: 10.1093/eurheartj/ehy288 ↗PubMed · 29901708 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →